Engaged Capital buys $13,949,055 stake in HeartWare International Inc (HTWR)

HeartWare International Inc (HTWR) : Engaged Capital scooped up 10,750 additional shares in HeartWare International Inc during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Aug 15, 2016. The investment management firm now holds a total of 240,750 shares of HeartWare International Inc which is valued at $13,949,055.HeartWare International Inc makes up approximately 3.96% of Engaged Capital’s portfolio.

Other Hedge Funds, Including , Price T Rowe Associates Inc Md reduced its stake in HTWR by selling 52,080 shares or 12.82% in the most recent quarter. The Hedge Fund company now holds 354,173 shares of HTWR which is valued at $20,520,784. Allianz Asset Management Ag added HTWR to its portfolio by purchasing 60,051 company shares during the most recent quarter which is valued at $3,479,355. Janus Capital Management sold out all of its stake in HTWR during the most recent quarter. The investment firm sold 742,335 shares of HTWR which is valued $43,010,890. Sivik Global Healthcare sold out all of its stake in HTWR during the most recent quarter. The investment firm sold 7,426 shares of HTWR which is valued $430,040.

On the company’s financial health, HeartWare International Inc reported $-0.62 EPS for the quarter, beating the analyst consensus estimate by $ 0.19 according to the earnings call on Jul 28, 2016. Analyst had a consensus of $-0.81. The company had revenue of $68.72 million for the quarter, compared to analysts expectations of $57.36 million. The company’s revenue was down -6.6 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $-0.47 EPS.

Many Wall Street Analysts have commented on HeartWare International Inc. HeartWare International Inc was Downgraded by Raymond James to ” Mkt Perform” on Jul 13, 2016. HeartWare International Inc was Downgraded by Leerink Partners to ” Mkt Perform” on Jul 11, 2016. HeartWare International Inc was Downgraded by Wells Fargo to ” Market Perform” on Jun 29, 2016.

Heartware International Inc. is a medical device company. The Company develops and manufactures miniaturized implantable heart pumps or ventricular assist devices for patients suffering from advanced heart failure. The HeartWare Ventricular Assist System (HVAD System) which includes a ventricular assist device (VAD) or blood pump patient accessories and surgical tools provides circulatory support for patients in the advanced stage of heart failure. The core of the HVAD System is a continuous flow blood pump the HVAD pump. The HVAD System is designed to be implanted adjacent to the heart avoiding abdominal surgery directly adjacent to the heart. The Company’s hybrid system is used for suspending the impeller. The impeller is suspended within the pump housing by the opposing forces of passive magnets and hydrodynamic thrust generated by the pump impeller which circulates a cushion of blood.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *